The Association of Biotechnology Led Enterprises (ABLE) is the premier industry association representing the biotechnology sector in India. Based in Bengaluru, the nation's biotech capital, we foster collaboration, advocate for progressive policies, and accelerate the growth of life sciences for a healthier and more sustainable future.
Join Our Network Learn MoreEstablished in 1998, the Association of Biotechnology Led Enterprises (ABLE) is a not-for-profit pan-India forum that represents the Indian biotechnology sector. Our membership spans biopharma, agri-biotech, industrial biotech, bioinformatics, and medical devices.
Headquartered in Bengaluru, Karnataka, ABLE works closely with government bodies, including the Department of Biotechnology (DBT), Ministry of Science & Technology, and state governments to shape a conducive ecosystem for research, innovation, and commercial success. Our mission is to make India a global biotech hub by 2030.
We provide a platform for networking, knowledge sharing, business development, and policy advocacy. Our initiatives are designed to address the unique challenges faced by startups, SMEs, and large enterprises in the life sciences domain.
Get in Touch
To catalyze the growth of the biotechnology industry in India by enabling innovation, facilitating investments, and creating a robust regulatory and policy framework that encourages research and commercialisation.
To position India as a world-class biotechnology innovation and manufacturing destination, contributing significantly to global health, food security, and environmental sustainability.
Integrity, Collaboration, Scientific Excellence, Inclusivity, and Sustainability guide all our endeavours. We believe in ethical business practices and equitable access to biotech benefits.
ABLE's work is organized across key verticals that represent the core pillars of the biotechnology industry.
Advancing vaccine development, biologics, biosimilars, and novel therapeutics. We work on streamlining clinical trials, regulatory pathways, and IP protection for pharma and biotech companies.
Promoting sustainable farming through GM crops, bio-fertilizers, and bio-pesticides. Focus on food security, climate-resilient crops, and farmer prosperity with science-based policy dialogue.
Championing bio-based manufacturing for chemicals, enzymes, and materials. Emphasizing circular economy, waste-to-value, and reducing industrial carbon footprint through biological processes.
Leveraging AI, ML, and big data for drug discovery, genomics, and precision medicine. Creating platforms for data sharing and fostering the Bio-IT startup ecosystem in India.
Supporting innovation in affordable, high-quality medical devices, IVDs, and point-of-care diagnostics. Engaging with CDSCO for regulatory harmonization and market access.
Bridging the industry-academia gap through specialized training programs, curriculum development, and certification to create a future-ready biotech workforce in India.
Join a powerful network of industry leaders, innovators, and changemakers.
ABLE membership is open to companies and institutions across the biotechnology value chain:
We offer tiered membership plans (Platinum, Gold, Silver, Startup) tailored to the size and needs of your organization.
To apply for membership or request a detailed benefits brochure, please contact our Membership Secretariat.
Email: [email protected]
Phone: +91-80-4115-6780 (Ext. 102)
Send Inquiry







ABLE organizes flagship conferences, workshops, and delegation meets to foster collaboration and learning.
Bangalore International Exhibition Centre, Bengaluru
Bio-India is our flagship event, attracting 5000+ delegates, 300+ exhibitors, and 100+ international partners. The summit features keynote sessions by global leaders, B2B meetings, startup pitch sessions, and an exclusive exhibition of biotech innovations. This year's theme is "Biotech for One Health: Integrating Human, Animal, and Environmental Well-being".
Register NowLondon & Oxford, United Kingdom
A curated delegation of 25 Indian biotech CEOs will visit leading UK research clusters, pharma giants, and investor forums to explore collaboration in cell & gene therapy, diagnostics, and digital health. The mission includes meetings with UK's Office for Life Sciences and the Association of the British Pharmaceutical Industry (ABPI).
Delegate Expression of InterestVirtual Event (Zoom)
A deep-dive webinar featuring experts from CDSCO, USFDA, and industry veterans on navigating the complex regulatory landscape for biosimilars in India and key export markets. The series includes case studies on filing strategies and post-marketing surveillance.
View Calendar & RegisterFor detailed agendas and registration, visit our events portal or contact [email protected].
Full Events Calendar
ABLE has proposed a 200% weighted tax deduction for R&D expenditure, creation of a dedicated Biotech Infrastructure Fund, and rationalization of GST on life-saving biologics. The recommendations aim to boost domestic innovation and manufacturing.
Read More
Three portfolio companies from ABLE's accelerator program secured Series A funding for novel bio-pesticides and drought-tolerant seed technologies. The connect event saw participation from 30+ VC firms and family offices.
Read More
The annual industry report highlights growth drivers: increasing demand for vaccines and biologics, government push for bio-manufacturing, and rising investment in R&D. The report also identifies talent gaps and regulatory hurdles as key challenges.
Read MoreWe welcome inquiries from members, potential partners, media, and policymakers.
8th Floor, Prestige Labyrinth,
No. 116, M.G. Road,
Bengaluru - 560001, Karnataka, India.
General Enquiries: +91-80-4115-6789
Membership Desk: +91-80-4115-6780
Events Team: +91-80-4115-6781
Media Relations: +91-80-4115-6782
General: [email protected]
Membership: [email protected]
Events: [email protected]
Media: [email protected]